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Abstract
Introduction
High beat-to-beat morphological variation (divergence) on the ventricular electrogram dur-
ing programmed ventricular stimulation (PVS) is associated with increased risk of ventricular
fibrillation (VF), with unclear mechanisms. We hypothesized that ventricular divergence is
associated with epicardial wavebreaks during PVS, and that it predicts VF occurrence.
Method and results
Langendorff-perfused rabbit hearts (n = 10) underwent 30-min therapeutic hypothermia
(TH, 30˚C), followed by a 20-min treatment with rotigaptide (300 nM), a gap junction modi-
fier. VF inducibility was tested using burst ventricular pacing at the shortest pacing cycle
length achieving 1:1 ventricular capture. Pseudo-ECG (p-ECG) and epicardial activation
maps were simultaneously recorded for divergence and wavebreaks analysis, respectively.
A total of 112 optical and p-ECG recordings (62 at TH, 50 at TH treated with rotigaptide)
were analyzed. Adding rotigaptide reduced ventricular divergence, from 0.13±0.10 at TH to
0.09±0.07 (p = 0.018). Similarly, rotigaptide reduced the number of epicardial wavebreaks,
from 0.59±0.73 at TH to 0.30±0.49 (p = 0.036). VF inducibility decreased, from 48±31% at
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TH to 22±32% after rotigaptide infusion (p = 0.032). Linear regression models showed that
ventricular divergence correlated with epicardial wavebreaks during TH (p<0.001).
Conclusion
Ventricular divergence correlated with, and might be predictive of epicardial wavebreaks
during PVS at TH. Rotigaptide decreased both the ventricular divergence and epicardial
wavebreaks, and reduced the probability of pacing-induced VF during TH.
Introduction
Sudden cardiac arrest (SCA) from ventricular arrhythmia (VA) constitutes a major public
health problem and accounts for approximately 50% of all cardiovascular deaths [1]. Despite
the progress been made in risk prediction of SCA, the greatest challenge is to identify reliable
risk predictors in patients with and without structural heart disease [2]. Beat-to-beat morpho-
logical variation (divergence) in the duration and amplitude of ventricular action potentials
has been recognized as a promising index of arrhythmic susceptibility and dynamic electrical
instability that predisposes to ventricular tachycardia (VT) and fibrillation (VF) [3]. Such sub-
tle morphological variation might manifest as T wave and microvolt T wave alternans in ECG,
which has been correlated with the risk for VA and SCA [4].
In patients with an implantable cardioverter-defibrillator (ICD), beat-to-beat morphologi-
cal variation might even be recorded by ICD leads before spontaneous VT and VF, suggesting
that these morphological variations might serve as a warn sign before VF and subsequent ICD
shocks [5]. In patients who were unable to achieve an adequate heart rate for beat-to-beat mor-
phological variation evaluation, programmed ventricular stimulation (PVS) using burst ven-
tricular pacing by electrodes or the atrial/ventricular leads of an implantable device has been
found to be a reliable alternative to predict VA [6]. By analyzing the electrograms from the
anti-tachycardia pacing episodes in the ICD, we also found that high ventricular divergence is
predictive of a failed therapy with a sensitivity and specificity of 81.9% and 65.9%, respectively
[7]. Although morphological variation has been liked to temporal dispersion of repolarization
in myocardial substrate, the mechanism by which the increased divergence leads to VA
remains unclear [8].
Epicardial wavebreaks resulting from multiple wave collisions may predispose the myocar-
dial substrate to fibrillate, serving as a potential source of VF [9, 10]. We reported earlier that
therapeutic hypothermia (TH) at 30˚C could create an arrhythmia substrate and increase
epicardial wavebreaks for VF maintenance in isolated rabbit hearts [11–13]. The infusion of
the gap junction modifier rotigaptide during TH could enhance ventricular conduction,
decrease epicardial wavebreaks, and reduce the incidence of VF [11]. Smith et al also found
that TH at 29˚C increased the beat-to-beat ECG variation during burst ventricular pacing,
which was associated with more inducible VT/VF in a canine experiment [14]. With this pro-
arrhythmic model, we were able to evaluate the myocardial substrate properties by delivering
burst ventricular pacing, while simultaneously measuring the divergence and epicardial
wavebreaks before and after rotigaptide infusion. We hypothesized that high ventricular diver-
gence at ECG during PVS is associated with more epicardial wavebreaks, leading to the occur-
rence of pacing-induced VF (PIVF). Enhancing cell-to-cell coupling using rotigaptide during
TH may simultaneously reduce ventricular divergence and epicardial wavebreaks, thus reduc-
ing the probability of PIVF. Understanding this mechanism might improve the patient safety
Ventricular divergence and epicardial wavebreaks
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during TH by delivering essential anti-arrhythmic therapy when increased beat-to-beat mor-
phological was detected before the recurrence VF.
Methods
The study protocol was approved by the Institutional Animal Care and Use Committee of Tai-
chung Veterans General Hospital (La-1051352).
Langendorff preparation and pseudo-ECG recordings
New Zealand white rabbits (3.0±0.3 kg, n = 19) were used. Before anesthetization, ketamine
(10 mg/kg) was injected intramuscularly to calm the animals. After 10–15 min, the rabbits
were intravenously injected with heparin (1,000 units) and anesthetized with sodium pento-
barbital (35 mg/kg) via the marginal ear vein. After a median sternotomy, the hearts were rap-
idly excised. The ascending aorta was cannulated and perfused with 37˚C oxygenated Tyrode’s
solution composed of (in mM): 125 NaCl, 4.5 KCl, 0.5 MgCl2, 24 NaHCO3, 1.8 NaH2PO4, 1.8
CaCl2, 5.5 glucose, and albumin (40 mg/L) in deionized water [11–13]. Coronary perfusion
pressure and flow rate were maintained at 60–65 mmHg and 35–45 ml/min, respectively [11–
13]. The hearts were also superfused in a thermostatized tissue bath. Pseudo-ECG (p-ECG)
was obtained through use of a pair of electrodes attached to both ventricles to determine the
ventricular rhythm [11]. A bipolar hook electrode was anchored to the right ventricular out-
flow tract (RVOT) for ventricular pacing.
Optical mapping
Epicardial activations in the anterior and posterior surfaces of the hearts were simultaneously
mapped by a two-camera optical mapping system [11–13]. The hearts were stained with di-
4-ANEPPS, and excited with 4 light-emitting diode modules (wavelength = 519±20 nm).
Induced fluorescence was collected by two image-intensified charge-coupled cameras (model
CA D1-0128T) [11–13]. Optical signals were gathered at 3.85-ms sampling intervals for 1,000
frames, acquired from 128x128 sites simultaneously over a 30x30 mm2 area in each aspect of
the heart. For each recording, optical data was acquired continuously for 3.85 sec (1,000 phase
maps). In previous studies, we have demonstrated that a similar camera system with this frame
rate could successfully capture wavebreaks and phase singularities (PSs) [15, 16]. Furthermore,
a long exposure time (3.85 sec) is essential to capture the whole process from the beginning of
burst pacing to the initiation of VF in optical mapping system. Cytochalasin-D (5 μM) was
used as an excitation-contraction un-coupler to minimize motion artifacts. In a typical time-
embedded phase portrait, the upstroke of the action potential corresponds to a phase ranging
from −3/4π to −1/4π, displayed in light-blue pixels on the representing color scale [11–13].
Induction of hypothermia (30˚C)
Two thermostatic systems were used to control the temperature of the hearts [11, 13]. By
switching between the two systems, the tissue bath temperature could be inter-changed
between warm (37˚C) and cool (30˚C) settings. To induce hypothermia, we shifted the ther-
mostatic system to the cool setting, and at the same time with the superfusate quickly replaced
with a cool Tyrode’s solution. During the cooling procedure, the temperature in the upper,
middle, and lower thirds of the tissue bath was checked every 1–2 min until 30˚C was achieved
at all levels. After reaching the target temperature (30˚C), the tissue bath was kept at this tem-
perature for an additional 5 min to ensure thermal homogeneity, before starting the study
protocol.
Ventricular divergence and epicardial wavebreaks
PLOS ONE | https://doi.org/10.1371/journal.pone.0228818 February 21, 2020 3 / 19
Study protocol
Protocol I: Rotigaptide on ventricular divergence, epicardial wavebreaks, and suscepti-
bility to VF during TH (30˚C) (n = 10). S1 pacing (2× diastolic threshold) protocol was used
to determine the ventricular conduction velocity (CV), action potential duration (APD), and
susceptibility to VF [11]. CV and APD were obtained with pacing cycle lengths (PCL) 400 to
120 ms at each stage. At baseline (37˚C), we progressively shortened the S1 PCL (frequency) to
identify the shortest PCL which achieved a 1:1 ratio ventricular capture. This PCL was selected
as the initial PCL for burst pacing to induce VF. Afterwards, the heart was cooled and main-
tained stably at 30˚C for 30 min. Five to ten burst pacing trains (30 sec in duration) using the
shortest PCL for ventricular capture were delivered to test the inducibility of VF. If VF could
be induced and persisted for >1 min, a defibrillation shock would be delivered through the
defibrillation coil, and this episode was considered to be a PIVF episode [17]. Afterwards, roti-
gaptide (300 nM) was infused into the heart for 20 min, and VF induction protocol was
repeated. We had chosen the concentration of rotigaptide to be 300 nM based upon the maxi-
mal effective concentration reported in the literature [18]. During the burst pacing period in
each VF inducibility test, both optical (for wavebreak evaluation) and p-ECG (for divergence)
data were simultaneously recorded.
Protocol II: Vehicle on electrophysiological properties and susceptibility to VF during
TH (30˚C) (n = 4). This protocol is the same as protocol I, except for using vehicle (saline)
instead of rotigaptide.
Protocol III: Different pacing sites on ventricular divergence, epicardial wavebreaks
and susceptibility to VF during TH (30˚C) (n = 3). Another bipolar hook electrode was
placed at the lateral aspect of left ventricle (LV), in addition to the original one at RVOT. This
protocol is the same as protocol I, except for that in each stage, ventricular pacing was per-
formed at RVOT firstly followed by pacing from LV.
Protocol IV: Extensive endocardial ablation on ventricular divergence, epicardial
wavebreaks and susceptibility to VF during TH (30˚C) (n = 2). This protocol is the same as
protocol I, except for using Lugol’s solution (5 g I2 and 10 g KI dissolved in 100 ml deionized
H2O) to paint the endocardial surface of both ventricles with 2 cotton swabs for 10–15 sec to
perform extensive endocardial ablation before starting the experimental protocol.
Data analysis
Construction of CV and APD restitution curves using S1 pacing method. CV and APD
and restitution curves were constructed as previously reported [11, 12]. Briefly, epicardial acti-
vation perpendicular to the propagating wavefront was selected to measure the CV. The
epicardial CV was evaluated by dividing the distance between 2 epicardial points with the con-
duction time (CT) using depolarization isochronal maps (Fig 1A). The CT between 2 epicar-
dial points was measured by 50% crossover of the action potential amplitude in activation
maps. We evaluated the CV at the centers of the anterior (A) and posterior (P) aspects of both
ventricles (RV and LV). The mean of the CVs from these 4 areas became the CV of the heart.
For APD evaluation, pixels at the center of the anterior and posterior surface of both ventricles
were selected to determine the APD80 (APD at 80% repolarization) and APD restitution
curves. The maximal slope of APD restitutions for each heart is the mean of the data from
these 4 sampling sites.
Phase mapping was performed to evaluate the wavefront characteristics, along with the
location and evolution of the PSs [12, 17]. A PS is defined as a site with an ambiguous phase
surrounded by pixels exhibiting a continuous phase progression from–π to +π. Because of the
close spatiotemporal correlation between PSs and wavebreak, PS has been a robust alternate
Ventricular divergence and epicardial wavebreaks
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representations of wavebreaks, serving as the source of VF [10]. By screening through phase
maps frame-by-frame, epicardial PSs were identified. To quantify wavebreaks during VF, the
number of PSs in each phase map was counted manually every 10 frames over the course of
1,000 frames in each optical recording [12]. Fast Fourier Transforms of p-ECGs (4 sec in dura-
tion) were used to determine the dominant frequency (DF) of each VF studied.
APD alternans was defined as the difference in APD80 on two consecutive beats of�3.85
ms during S1 pacing [11]. Spatially concordant alternans (SCA) was defined as APD alterna-
tion in phase spatially, whereas spatially discordant alternans (SDA) was defined as an alterna-
tion out of phase spatially [19]. Therefore, the SDA threshold was defined as the longest S1
PCL at which SDA was detected.
We have previously used the beat-to-beat morphologic variation (divergence) to predict the
response of anti-tachycardia pacing on VT in patients with structural heart disease [7]. Note
that the term of divergence is also known for the measure of the "distance" of one probability
Fig 1. A, representative isochronal maps (from heart #10) at pacing cycle length (PCL) 350 ms during baseline (BL, 37˚C), therapeutic hypothermia (TH, 30˚C), and
after rotigaptide (Roti) infusion. These maps are constructed by consecutive frames shown in different colors (1 frame = 3.85 ms), and used for evaluation of ventricular
conduction velocity (CV). The average CVs of each stage are shown below. �Pacing site. B, CVs during these 3 stages at different PCLs. C, representative action potential
duration (APD) restitution curves from a site at left ventricle (from heart #9) during these 3 stages. D, maximal slope of APD restitutions at there 3 stages.
https://doi.org/10.1371/journal.pone.0228818.g001
Ventricular divergence and epicardial wavebreaks
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distribution to the other in statistics, which is also known as “relative entropy” [20]. We
employed the concept to analyze the degree of morphologic variation of each activation on p-
ECG in this study. The maximal activation (local peak) of each p-ECG was identified firstly.
Each p-ECG was then normalized with respect to the maximum values. The length of each p-
ECG was defined by 80% of the average duration between the two consecutive activations.
Each p-ECG was then extracted and aligned by the point of maximal activation so as to prevent
the morphologic variation from the interference caused by the varying interval of two con-
secutive activations and the varying signal strength. Finally those aligned waveforms were
applied to the proposed divergence equation. The ith normalized p-ECG can be denoted by
Xi ¼ sk  Lþ1
2
. . . sk . . . :skþL  1
2
n o
, where L is the data length of the ith p-ECG, and sk is the data
point with the maximum voltage. A template p-ECG �X was constructed by averaging all of the
normalized p-ECG, i.e. �X ¼ 1N
Pi¼N
i¼1 Xi for an episode of N p-ECG. The morphologic variation
between the ith p-ECG and template was derived by calculating the standard deviation (std) of
the difference between ith p-ECG and template, i.e. dðXi; �XÞ ¼ stdðXi   �XÞ, for which is used
to reflect the averaged 2-norm distance between the ith p-ECG and template. The overall mor-
phologic variation was finally obtained by averaging all of the morphologic variations regard-
ing the ith p-ECG, which is the “divergence” of the p-ECG, i.e., Divergence ¼ 1N
PN
i¼1 dðXi; �XÞ
[7]. Note that the divergence will be zero for an episode with identical ventricular p-ECG.
Statistical analysis
Data were presented as mean± SD. We used the non-parametric Wilcoxon signed-rank test
for paired comparisons (within the groups), and the Mann-Whitney U test for independent
comparisons (between the groups). Analysis of variance (ANOVA) was used to compare the
means of three or more groups, with p-values adjusted by the Bonferroni method. Fisher’s
exact test was used to compare the categorical data between groups. Probability values of
p�0.05 were considered statistically significant.
Results
Rotigaptide on CV and APD restitutions during TH (30˚C)
The cycle lengths of baseline spontaneous beats during TH were 1153±262 ms at the beginning
of the protocol, and 1182±385 ms before rotigaptide treatment. The effects of rotigaptide on
CV and APD restitutions during TH were shown in Fig 1. Compared to baseline, CVs were
decreased during TH (Fig 1A and 1B). Rotigaptide increased the CVs during TH (i.e., at PCL
350 ms, TH: 61.6±6.3 cm/s, TH+Roti: 67.2±5.5 cm/s, p = 0.012) (Fig 1B). Compared to base-
line, APDs were prolonged during TH. However, rotigaptide did not change the APDs during
TH (i.e., at PCL 350 ms, TH: 238±12 ms, TH+Roti: 243±15 ms, p = 0.28). The maximal slope
of APD restitution was increased from 1.00±0.12 at baseline to 1.73±0.39 during TH (p =
0.001) (Fig 1C and 1D). However, the maximal slope of APD restitution was not changed by
rotigaptide during TH (p = 0.60). In control group, rotigaptide did not change APDs (i.e., at
PCL 350 ms, TH: 232±14 ms, TH+vehicle: 238±9 ms, p = 0.22), CV (i.e., at PCL 350 ms, TH:
63.7±16.4 cm/s, TH+vehicle: 63.8±19.9 cm/s, p = 0.98) and maximal slope of APD restitutions
(TH: 2.01±0.57, TH+vehicle: 2.26±1.23, p = 0.70).
Effects of rotigaptide on VF inducibility during TH
Of the 10 hearts in the rotigaptide group, a total of 112 optical/p-ECG recordings (62 at TH, 50
at TH plus rotigaptide) during burst ventricular pacing were analyzed. The experiment
Ventricular divergence and epicardial wavebreaks
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duration of each heart was 126±15 min (S1 Fig). S1 Table showed the PCLs and results of each
pacing attempt in the rotigaptide group. Two hearts (#1 and #6) did not develop any PIVF epi-
sode throughout the pacing protocol. The PCLs used for VF induction were similar both
before (206±40 ms, n = 62) and after (204±46 ms, n = 50) rotigaptide during TH (p = ns). Dur-
ing TH, rotigaptide decreased the percentage of PIVF episodes from 55% (34 out of 62 epi-
sodes) to 34% (17 out of 50 episodes) (p = 0.036) (Fig 2A). The PCL used in PIVF episodes
(196±37 ms, n = 51) is shorter than that in non-PIVF episodes (212±45 ms, n = 61, p = 0.044).
In the PIVF episodes, the DF of the VFs were indifferent before (6.7±1.5 Hz, n = 34) and after
(6.2±1.1 Hz, n = 17) rotigaptide infusion (p = 0.20). The VF inducibility also decreased from
48±31% at TH to 22±32% after rotigaptide infusion (p = 0.032) (Fig 2B). In control group, the
VF inducibility was not changed with vehicle infusion (TH: 25±25%, TH+vehicle: 58±50%,
p = 0.16).
Rotigaptide on ventricular divergence and epicardial wavebreaks during
TH
Fig 3 shows an example of ventricular divergence both before (Fig 3A) and after rotigaptide
infusion (Fig 3B) during TH. The ventricular divergence was higher in the PIVF episodes (0.16
±0.11, n = 51) than that of the non-PIVF episodes (0.09±0.07, n = 61) (p<0.001) (Fig 4A) dur-
ing TH. Rotigaptide decreased the ventricular divergence from 0.13±0.10 (n = 62) at TH to
0.09±0.07 (n = 50) after being added rotigaptide (p = 0.018) (Fig 4B). Similar to the changes in
divergence, the PIVF (0.85±0.71) episodes had a higher number of epicardial wavebreaks than
those of the non-PIVF (0.11±0.26) episodes during TH (p<0.001) (Fig 4C). The number of
Fig 2. A, Rotigaptide (Roti) on pacing-induced ventricular fibrillation (VF) episodes during therapeutic hypothermia (TH, 30˚C). B, Rotigaptide on the probability of
pacing-induced VF during TH.
https://doi.org/10.1371/journal.pone.0228818.g002
Ventricular divergence and epicardial wavebreaks
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epicardial wavebreaks also dropped from 0.59±0.73 at TH to 0.30±0.49 after rotigaptide treat-
ment (p = 0.036) (Fig 4D). The life spans of each wavebreak in PIVF episodes were similar
before (102±48 ms) and after (91±32 ms) rotigaptide (p = 0.50).
Fig 5 shows the dynamic changes in beat-to-beat ventricular divergence and epicardial
wavebreaks in PIVF and non-PIVF episodes, as well as the changes with and without rotigap-
tide. In these episodes, divergence abruptly increased during burst pacing, and then reached a
steady state level after the 6th beat (Fig 5A). Fig 5B shows that the PIVF episodes have a higher
divergence than those of the non-PIVF episodes with (PIVF: 0.14±0.10, non-PIVF: 0.07±0.03,
p = 0.02) or without (PIVF: 0.16±0.11, non-PIVF: 0.10±0.05, p = 0.004) rotigaptide treatment.
In the non-PIVF episodes, the divergence was lower when rotigaptide was introduced (0.07
±0.03), than it was without (0.10±0.05) during TH (p = 0.04). In the PIVF episodes, the diver-
gence was unaffected by the rotigaptide infusion (p = 0.41). Similar to the changes in diver-
gence, the epicardial wavebreak number progressively increased during pacing in the PIVF
episodes, while the wavebreak numbers remained few in the non-PIVF episodes (Fig 5C). The
Fig 3. Two examples of divergence analysis at burst ventricular pacing cycle length (PCL) of 240 ms during therapeutic hypothermia (TH, 30˚C) in heart #10. A,
without rotigaptide, this episode shows significant morphological variation during pacing with a high divergence of 0.1107. VF occurred immediately after stopping
pacing. B, with rotigaptide, this episode shows minimal morphological change during pacing with a low divergence of 0.0272. Normal rhythm was observed
immediately after stopping pacing.
https://doi.org/10.1371/journal.pone.0228818.g003
Ventricular divergence and epicardial wavebreaks
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PIVF episodes also had more epicardial wavebreaks than those of the non-PIVF episodes, both
with (PIVF: 0.86±0.53, non-PIVF: 0.05±0.10, p<0.001) and without (PIVF: 0.85±0.80, non-
PIVF: 0.22±0.40, p = 0.005) rotigaptide (Fig 5D). In non-PIVF episodes, the wavebreak num-
ber was lower with rotigaptide (0.05±0.10) than it was without rotigaptide (0.22±0.40) during
TH (p = 0.03). In the PIVF episodes, the wavebreak number was similar with or without roti-
gaptide (p = 0.96).
Fig 6 provides an example of simultaneous epicardial activation and ventricular divergence
during ventricular pacing in a rotigaptide-treated non-PIVF episode. The ventricular diver-
gence was low, and epicardial wavebreaks were also few during pacing. Conversely, Fig 7 is an
example of a PIVF episode in the absence of rotigaptide during TH. In this episode, the ven-
tricular divergence and epicardial wavebreak numbers were both high during pacing. Unidi-
rectional block and wavebreak occurred soon during pacing with sustained reentry
degenerated into complex wavefront collisions and fibrillatory conduction (S1 Movie).
Fig 4. Ventricular divergence (A, B) and epicardial wavebreaks (C, D) in the pacing-induced ventricular fibrillation (PIVF) and non-PIVF (no VF) episodes with and
without rotigaptide (Roti) infusion during therapeutic hypothermia (TH, 30˚C).
https://doi.org/10.1371/journal.pone.0228818.g004
Ventricular divergence and epicardial wavebreaks
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In the 112 pacing induction episodes, SDA was observed in 50 episodes while SCA was seen
in 38 episodes. The divergence in the SDA episodes (0.11±0.06) was higher than that in the
SCA episodes (0.08±0.04) (p = 0.03).
Correlation between divergence and epicardial wavebreaks
Linear regression analysis showed a correlation existed between ventricular divergence and
the numbers of epicardial wavebreaks during ventricular pacing at TH (p<0.001, R2 = 0.334,
Fig 8). This correlation between divergence and wavebreaks also exists in PIVF (p<0.001, R2 =
0.199) and non-PIVF (p<0.001, R2 = 0.261) episodes. In the episodes of PCL�200, the correla-
tion between divergence and wavebreak was significant (p<0.001, R2 = 0.313). In the episodes
Fig 5. Beat-to-beat dynamic ventricular divergence (A, B) and epicardial wavebreaks (WBs) (C, D) during burst pacing in the pacing-induced ventricular fibrillation
(PIVF) and non-PIVF episodes with and without rotigaptide (Roti) infusion during therapeutic hypothermia (TH, 30˚C).
https://doi.org/10.1371/journal.pone.0228818.g005
Ventricular divergence and epicardial wavebreaks
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of PCL>200, the correlation between divergence and wavebreak was also significant
(P<0.001, R2 = 0.224).
Different pacing sites on the divergence and VF inducibility
The divergence of the PIVF episodes was not different between RV (0.15±0.04) and LV (0.15
±0.07) pacing (p = 0.97). Also, the divergence of the non-PIVF episodes was not different
between RV (0.12±0.07) and LV (0.11±0.05) pacing (p = 0.60). The inducibility of VF was also
similar before (p = 0.20) and after (p = 0.23) rotigaptide infusion between RV and LV pacing.
These findings indicated that the divergences and VF inducibility in this model were not
affected by changing the pacing sites.
Extensive endocardial ablation on the divergence and VF inducibility
The divergence in the PIVF episodes was similar between the ablated (0.20±0.11, protocol IV)
and non-ablation hearts (0.16±0.11, protocol I) (p = 0.38). The divergence in the non-PIVF
Fig 6. Simultaneous recordings of epicardial activations (A), pseudo-ECG (B), dynamic changes of divergence (C), and epicardial wavebreaks (D) at the start of burst
ventricular pacing at pacing cycle length (PCL) 200 ms during therapeutic hypothermia (TH, 30˚C) in an episode of low divergence (data is from heart #7). Note that the
divergence increased to 0.040 at the 3rd beat and decreased to 0.028 at the 17th beat. VF was not inducible in this episode (B). Black triangles in panel A indicate points of
wavebreaks (WBs).
https://doi.org/10.1371/journal.pone.0228818.g006
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episodes was similar between the ablated (0.09±0.02, protocol IV) and non-ablation hearts
(0.09±0.07, protocol I) (p = 0.81). The wavebreaks in the PIVF episodes was similar between
the ablated (0.52±0.25, protocol IV) and non-ablation hearts (0.85±0.71, protocol I) (p = 0.36).
The wavebreaks in the non-PIVF episodes was similar between the ablated (0.10±0.12, proto-
col IV) and non-ablation hearts (0.11±0.26, protocol I) (p = 0.83). These findings indicated
that endocardial sources might not have impact on the epicardial wavebreaks in this model.
Rotigaptide decreased the VF inducibility from 50±14% to 0% (p = 0.04).
Discussion
The major findings of this study are (1) The changes in ventricular divergence after rotigaptide
infusion paralleled with the changes in epicardial wavebreaks in both the PIVF and non-PIVF
episodes during TH. (2) Linear regression analysis showed a correlation between ventricular
Fig 7. Simultaneous recordings of epicardial activations (A), pseudo-ECG (B), dynamic changes of divergence (C), and epicardial wavebreaks (D) at the start of burst
ventricular pacing at pacing cycle length (PCL) 200 ms during therapeutic hypothermia (TH, 30˚C) in an episode of high divergence (data is from heart #7). Note that
the divergence increased to 0.031 at the 2nd beat and remained as high as 0.63 at the 17th beat. VF was inducible after stopping pacing (B). Black triangles in panel A
indicate points of wavebreak (WBs).
https://doi.org/10.1371/journal.pone.0228818.g007
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divergence and the number of epicardial wavebreaks during ventricular pacing at TH. (3) Roti-
gaptide increased CV, and decreased both the ventricular divergence and the number of
epicardial wavebreaks at ventricular pacing, and decreased the probability of PIVF during TH.
Beat-to-beat morphological variation on arrhythmic susceptibility
Beat-to-beat morphological variation (divergence) in the duration and amplitude of ventricu-
lar electrograms been shown to predict VA and SCA among diverse patients with ischemic
and non-ischemic cardiomyopathy [3]. Such subtle morphological variation might manifest as
T wave alternans in ECG, which has been correlated with risk for VA and SCA [4]. By analyz-
ing ambulatory ECG from patients, Shusterman et al found that the beat-to-beat morphologi-
cal oscillations increased before the onset of spontaneous VF, indicating that these
morphological variations might have a temporal relationship with the onset of VF [21]. In
patients with an ICD, beat-to-beat morphological variation might even be recorded by ICD
Fig 8. Linear correlation of ventricular divergence versus epicardial wavebreaks (WBs) in all burst pacing episodes during therapeutic hypothermia (TH, 30˚C).
https://doi.org/10.1371/journal.pone.0228818.g008
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leads before spontaneous VT and VF [5]. In patients with inadequate or irregular heart beat
for divergence evaluation, PVS using burst ventricular pacing by electrodes or the atrial/ven-
tricular leads of an implantable device has been found to be a reliable alternative to predict VA
[6]. Although these findings indicated that these morphological variations might serve as a
warn sign before VF, the mechanisms by which increased morphological variation lead to VA
remains unclear.
Several mechanisms have been proposed to link the increased divergence with the occur-
rence of VA [22]. Increased heart rate could induce concordant alternans, which could prog-
ress to discordant alternans as the heart rate speed up and produce beat-to-beat morphological
variation on ECG [23]. Discordant alternans causes steep gradients of repolarization that can
provide the substrate for unidirectional functional block and the initiation VA [19]. Other
study suggested that beat-to-beat morphological variation on ECG reflected increased hetero-
geneity in ventricular repolarization secondary to a steep repolarization restitution curve [22].
In this study, we observed a direct correlation between ventricular divergence and epicardial
wavebreaks that leads to VF occurrence, providing another mechanism of increased morpho-
logical variation contributed to VF via epicardial wavebreak. Further studies are warrant to
evaluate if this phenomenon still occurs in structurally diseased hearts.
Ventricular divergence and epicardial wavebreaks on VF occurrence
TH has been shown to improve neurological outcomes in patients resuscitated from cardiac
arrest [24]. Chorro et al reported that acute reduction of ventricular temperature to<20˚C
might simplify VF activation patterns and terminated VF [25]. However, the temperature
(<20˚C) they used is far below the therapeutic range of hypothermia. Harada et al found that
TH at 30˚C in 2-dimensional rabbit ventricles enhanced wavebreaks and regeneration of new
spiral waves during VF, facilitating VT and VF maintenance. This finding is consistent with
the pro-arrhythmic model used in the current study [26]. In contrast, TH at 33˚C might
increase the chance of spiral wave collision and VT/VF self-termination, indicating that 33˚C
is a safe temperature for clinical use [26].
In this hypothermic (30˚C) and pro-arrhythmic rabbit heart model, we found that the
divergence had changed in parallel with the changes in epicardial wavebreaks during TH. To
establish their correlation, we used rotigaptide treatment to reduce epicardial wavebreaks as in
our previous study [11], and found that the divergence had decreased as well (Fig 4B and 4D).
The infusion of rotigaptide also simultaneously reduced both divergence (Fig 5B) and waveb-
reaks (Fig 5D) in episodes of non-PIVF. Linear regression analysis showed that the divergence
and epicardial wavebreak numbers were correlated. These findings suggest that ventricular
divergence on ECG could be a predictor of epicardial wavebreaks during PVS.
In the present study, episodes of PIVF showed a higher divergence and more epicardial
wavebreaks when compared to episodes of non-PIVF. Infusion of rotigaptide not only reduced
both divergence and epicardial wavebreaks, but also decreased the probability of PIVF, indi-
cating that reducing both divergence and epicardial wavebreaks could lead to less VF. In multi-
ple wavelet hypothesis, wavebreaks resulting from collisions of propagation mother wavelets
might generate daughter wavelets in a self-sustaining turbulent process to maintain VF [27].
Using optical mapping techniques, PS found on phase maps is the area of ambiguous activa-
tion state which underlies the formation of rotor and wavebreaks, and serves as a source of VF
[10]. Taken together, the increase in divergence during ventricular pacing could indicate mul-
tiple epicardial wavebreaks, which is essential for VF maintenance. Infusion of rotigaptide low-
ered the number of epicardial wavebreaks, and reduced the probability of PIVF.
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Because epicardial wavebreaks cannot be observed in clinical practice, patients with high
ventricular divergence during PVS should be carefully evaluated in order to identify underly-
ing instability of myocardial substrate. Recently, a 3D multi-electrode vest which can gather
cardiac electrophysiological data from the body surface has become widely used [28]. With
this technology, one would be able to obtain bi-atrial and bi-ventricular, 3-D cardiac activation
maps during PVS, and thus providing a direct correlation with divergence and epicardial
wavebreaks in the future.
Anti-arrhythmic mechanisms of rotigaptide during TH
Rotigaptide is an anti-arrhythmic peptide which enhances gap junction intercellular conduc-
tance between cardiomyocytes, without changing the membrane conductance [29]. Kjolbye
et al reported that rotigaptide hinders the onset of arrhythmogenic SDA, and protects ventric-
ular tachyarrhythmia in an ischemic guinea pig heart model [30]. We also found that rotigap-
tide could enhance CV, prevent SDA, and decrease VF occurrence in hypothermic (30˚C)
isolated rabbit hearts [11]. In the present study, we discovered that ventricular beat-to-beat
variation (divergence) during burst pacing was decreased by rotigaptide. Additionally, ventric-
ular divergence in SDA episodes is higher than that in SCA episodes. It is possible that high
ventricular divergence prior to rotigaptide infusion during TH is related to SDA in a minor
extent, and that rotigaptide increased CV (Fig 1), suppressed the SDA and reduced the diver-
gence [11]. This speculation is supported by the observation that SDA causes epicardial waveb-
reaks and VF occurrence in guinea pig hearts [31]. Although changing the APD restitution
curve may predispose to wavebreak and VF during pacing [32], our data showed that rotigap-
tide did not affect APD restitution during TH (Fig 1) [11]. Therefore, the suppression of diver-
gence by rotigaptide could be associated with a reduced SDA, wavebreak number, and less
inducible VF. Further studies are still needed to test this hypothesis.
Clinical implications
Beat-to-beat morphological variation during PVS is a robust indicator for epicardial waveb-
reak, which may lead to VA. An ICD has been widely used to effectively prevent SCA and pro-
long patient survival in primary and secondary prevention clinical trials [33]. To minimizing
any unnecessary ICD shock, one approach is to early identify the vulnerable myocardial sub-
strate at high risk of VA before VA occurrence. Given the prevalence of ventricular pacing in
ICD patients, increased beat-to-beat morphological variation during ventricular pacing might
be a warn sign of epicardial wavebreaks and recurrent VA. Delivery of essential anti-arrhyth-
mic therapy or revascularization before VA occurrence might be of great value to prevent elec-
trical storm. In patients resuscitated from SCA who are undergoing TH, rotigaptide infusion
may decrease ventricular divergence and epicardial wavebreaks, thus reducing the risk for
recurrent VA.
Limitations
The present study had some limitations. Firstly, we used this hypothermic model to elucidate
the correlation between ventricular divergence and epicardial wavebreak during PVS in nor-
mal ventricles. Whether our experimental conclusions can be extended to other experimental
models (ischemic or heart failure models) remains to be verified. Using computer simulation
would also be beneficial in controlling experimental conditions and prove our hypothesis in
the future. Secondly, our optical mapping data included PSs recorded from the epicardial sur-
face. One cannot exclude the possibility that intramural wavebreaks were altered by the use of
rotigaptide, and therefore had contributed to changes in divergence. Thirdly, the effects of
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rotigaptide on divergence and wavebreaks during TH were evaluated exclusively after short
treatments of 20 minutes. Whether longer durations of rotigaptide infusion (i.e., 12–24 hours,
as compliant with clinical guidelines) could similarly reduce divergence and wavebreak
remains to be determined. Fourthly, we chose the maximal effective concentration (300 nM)
to evaluate the divergence-wavebreaks relationship in normal ventricles. Whether the positive
correlation observed in this study could be applied to rotigaptide at other concentration or in
the presence of heterogeneous structures remains to be explored. Although linear regression
showed a correlation between ventricular divergence and the numbers of epicardial waveb-
reaks, the low R square value indicated that divergence along might not strongly predicted the
wavebreaks numbers. Interpreting this data should be with caution. Finally, despite the
electrophysiological properties including APD and CV were not changed with rotigaptide or
vehicle infusion during TH, we could not completely exclude the possibility that protein func-
tioning and metabolisms have been altered by TH per se. Further control study at 37˚C is
warrant.
Conclusions
Ventricular beat-to-beat morphological variation evaluated as divergence was correlated with,
and might be predictive of, epicardial wavebreak during ventricular pacing at TH. Treatment
with rotigaptide reduced both the ventricular divergence and epicardial wavebreak at ventricu-
lar pacing, and decreased the probability of PIVF during TH. Enhancing cell-to-cell coupling
could be a novel approach toward improving the stability of myocardial substrate during TH.
Supporting information
S1 Fig. Experimental time of the study protocol.
(TIF)
S1 Table. Pacing cycle lengths and results of each attempt before and after rotigaptide
treatment during hypothermia (30˚C).
(DOCX)
S1 Movie. Example of pacing induction of VF at PCL 200 ms during hypothermia.
(AVI)
S1 Data. Divergence raw data during hypothermia.
(XLSX)
Acknowledgments
We thank Ya-Wen Hsu, Hung-De Yuan, and Shane Su for their technical assistance. Rotigap-
tide was supplied by Zealand Pharma, Glostrup, Denmark.
Author Contributions
Data curation: Yu-Cheng Hsieh, Wan-Hsin Hsieh, Men-Tzung Lo.
Formal analysis: Yu-Cheng Hsieh, Wan-Hsin Hsieh, Cheng-Hung Li, Ying-Chieh Liao,
Jiunn-Cherng Lin, Chi-Jen Weng, Men-Tzung Lo, Ta-Chuan Tuan, Yenn-Jiang Lin, Wei-
Wen Lin.
Investigation: Yenn-Jiang Lin.
Methodology: Shien-Fong Lin, Jin-Long Huang, Tsu-Juey Wu, Shih-Ann Chen.
Ventricular divergence and epicardial wavebreaks
PLOS ONE | https://doi.org/10.1371/journal.pone.0228818 February 21, 2020 16 / 19
Project administration: Wan-Hsin Hsieh.
Resources: Ketil Haugan, Bjarne D. Larsen.
Writing – original draft: Yu-Cheng Hsieh.
Writing – review & editing: Hung-I Yeh, Ketil Haugan, Tsu-Juey Wu, Shih-Ann Chen.
References
1. Myerburg RJ, Junttila MJ. Sudden cardiac death caused by coronary heart disease. Circulation. 2012;
125(8):1043–52. https://doi.org/10.1161/CIRCULATIONAHA.111.023846 PMID: 22371442.
2. Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, et al. 2017 AHA/ACC/
HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden
cardiac death: a report of the American College of Cardiology/American Heart Association Task Force
on Clinical Practice Guidelines and the Heart Rhythm Society. Journal of the American College of Cardi-
ology. 2018; 72(14):e91–e220. https://doi.org/10.1016/j.jacc.2017.10.054 PMID: 29097296
3. Nearing BD, Verrier RL. Progressive increases in complexity of T-wave oscillations herald ischemia-
induced ventricular fibrillation. Circulation research. 2002; 91(8):727–32. https://doi.org/10.1161/01.res.
0000038887.17976.33 PMID: 12386150.
4. Gold MR, Bloomfield DM, Anderson KP, El-Sherif NE, Wilber DJ, Groh WJ, et al. A comparison of T-
wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for
arrhythmia risk stratification. Journal of the American College of Cardiology. 2000; 36(7):2247–53.
https://doi.org/10.1016/s0735-1097(00)01017-2 PMID: 11127468.
5. Swerdlow C, Chow T, Das M, Gillis AM, Zhou X, Abeyratne A, et al. Intracardiac electrogram T-wave
alternans/variability increases before spontaneous ventricular tachyarrhythmias in implantable cardio-
verter-defibrillator patients: a prospective, multi-center study. Circulation. 2011; 123(10):1052–60.
https://doi.org/10.1161/CIRCULATIONAHA.110.986364 PMID: 21357826
6. Raatikainen MJ, Jokinen V, Virtanen V, Hartikainen J, Hedman A, Huikuri HV, et al. Microvolt T-wave
alternans during exercise and pacing in patients with acute myocardial infarction. Pacing and clinical
electrophysiology: PACE. 2005; 28 Suppl 1:S193–7. https://doi.org/10.1111/j.1540-8159.2005.00110.x
PMID: 15683495.
7. Tuan TC, Lo MT, Lin YJ, Hsieh WH, Lin C, Huang NE, et al. The use of signal analyses of ventricular
tachycardia electrograms to predict the response of antitachycardia pacing in patients with implantable
cardioverter-defibrillators. Journal of cardiovascular electrophysiology. 2014; 25(4):411–7. https://doi.
org/10.1111/jce.12340 PMID: 24320556.
8. Verrier RL, Klingenheben T, Malik M, El-Sherif N, Exner DV, Hohnloser SH, et al. Microvolt T-wave
alternans: physiological basis, methods of measurement, and clinical utility—consensus guideline by
International Society for Holter and Noninvasive Electrocardiology. Journal of the American College of
Cardiology. 2011; 58(13):1309–24. https://doi.org/10.1016/j.jacc.2011.06.029 PMID: 21920259
9. Zaitsev AV, Guha PK, Sarmast F, Kolli A, Berenfeld O, Pertsov AM, et al. Wavebreak formation during
ventricular fibrillation in the isolated, regionally ischemic pig heart. Circulation research. 2003; 92
(5):546–53. https://doi.org/10.1161/01.RES.0000061917.23107.F7 PMID: 12600877.
10. Hayashi H, Lin SF, Chen PS. Preshock phase singularity and the outcome of ventricular defibrillation.
Heart rhythm. 2007; 4(7):927–34. https://doi.org/10.1016/j.hrthm.2007.02.028 PMID: 17599680.
11. Hsieh YC, Lin JC, Hung CY, Li CH, Lin SF, Yeh HI, et al. Gap junction modifier rotigaptide decreases
the susceptibility to ventricular arrhythmia by enhancing conduction velocity and suppressing discordant
alternans during therapeutic hypothermia in isolated rabbit hearts. Heart rhythm. 2016; 13(1):251–61.
https://doi.org/10.1016/j.hrthm.2015.07.023 PMID: 26188250.
12. Hsieh YC, Lin SF, Lin TC, Ting CT, Wu TJ. Therapeutic hypothermia (30 degrees C) enhances arrhyth-
mogenic substrates, including spatially discordant alternans, and facilitates pacing-induced ventricular
fibrillation in isolated rabbit hearts. Circulation journal: official journal of the Japanese Circulation Soci-
ety. 2009; 73(12):2214–22. https://doi.org/10.1253/circj.cj-09-0432 PMID: 19789414.
13. Hsieh YC, Yeh HI, Lin SF, Hsu YW, Huang JL, Lin TC, et al. Short-duration therapeutic hypothermia
causes prompt connexin43 gap junction remodeling in isolated rabbit hearts. Circulation journal: official
journal of the Japanese Circulation Society. 2011; 75(7):1706–16. https://doi.org/10.1253/circj.cj-10-
1001 PMID: 21613744.
14. Smith JM, Clancy EA, Valeri CR, Ruskin JN, Cohen RJ. Electrical alternans and cardiac electrical insta-
bility. Circulation. 1988; 77(1):110–21. https://doi.org/10.1161/01.cir.77.1.110 PMID: 3335062.
Ventricular divergence and epicardial wavebreaks
PLOS ONE | https://doi.org/10.1371/journal.pone.0228818 February 21, 2020 17 / 19
15. Chou CC, Nihei M, Zhou S, Tan A, Kawase A, Macias ES, et al. Intracellular calcium dynamics and
anisotropic reentry in isolated canine pulmonary veins and left atrium. Circulation. 2005; 111(22):2889–
97. https://doi.org/10.1161/CIRCULATIONAHA.104.498758 PMID: 15927973.
16. Hwang GS, Hayashi H, Tang L, Ogawa M, Hernandez H, Tan AY, et al. Intracellular calcium and vulner-
ability to fibrillation and defibrillation in Langendorff-perfused rabbit ventricles. Circulation. 2006; 114
(24):2595–603. Epub 2006/11/23. https://doi.org/10.1161/CIRCULATIONAHA.106.630509 PMID:
17116770.
17. Hsieh YC, Chang PC, Hsueh CH, Lee YS, Shen C, Weiss JN, et al. Apamin-sensitive potassium current
modulates action potential duration restitution and arrhythmogenesis of failing rabbit ventricles. Circula-
tion Arrhythmia and electrophysiology. 2013; 6(2):410–8. Epub 2013/02/20. https://doi.org/10.1161/
CIRCEP.111.000152 PMID: 23420832; PubMed Central PMCID: PMC3678988.
18. Shiroshita-Takeshita A, Sakabe M, Haugan K, Hennan JK, Nattel S. Model-Dependent Effects of the
Gap Junction Conduction–Enhancing Antiarrhythmic Peptide Rotigaptide (ZP123) on Experimental
Atrial Fibrillation in Dogs. Circulation. 2007; 115(3):310–8. https://doi.org/10.1161/CIRCULATIONAHA.
106.665547 PMID: 17224477
19. Pastore JM, Girouard SD, Laurita KR, Akar FG, Rosenbaum DS. Mechanism linking T-wave alternans
to the genesis of cardiac fibrillation. Circulation. 1999; 99(10):1385–94. https://doi.org/10.1161/01.cir.
99.10.1385 PMID: 10077525.
20. Ullah A. Entropy, divergence and distance measures with econometric applications. Journal of Statisti-
cal Planning and Inference. 1996; 49(1):137–62.
21. Shusterman V, Goldberg A, London B. Upsurge in T-Wave Alternans and Nonalternating Repolarization
Instability Precedes Spontaneous Initiation of Ventricular Tachyarrhythmias in Humans. Circulation.
2006; 113(25):2880–7. https://doi.org/10.1161/CIRCULATIONAHA.105.607895 PMID: 16785339
22. Weiss JN, Chen P-S, Qu Z, Karagueuzian HS, Garfinkel A. Ventricular fibrillation: how do we stop the
waves from breaking? Circulation research. 2000; 87(12):1103–7. https://doi.org/10.1161/01.res.87.12.
1103 PMID: 11110766
23. Tachibana H, Kubota I, Yamaki M, Watanabe T, Tomoike H. Discordant ST alternans contributes to for-
mation of reentry: a possible mechanism of reperfusion arrhythmia. American Journal of Physiology-
Heart and Circulatory Physiology. 1998; 275(1):H116–H21.
24. Donnino MW, Andersen LW, Berg KM, Reynolds JC, Nolan JP, Morley PT, et al. Temperature manage-
ment after cardiac arrest: an advisory statement by the advanced life support task force of the interna-
tional liaison committee on resuscitation and the American Heart Association emergency
cardiovascular care committee and the council on cardiopulmonary, critical care, Perioperative and
Resuscitation. Circulation. 2015; 132(25):2448–56. https://doi.org/10.1161/CIR.0000000000000313
PMID: 26434495
25. Chorro FJ, Guerrero J, Ferrero A, Tormos A, Mainar L, Millet J, et al. Effects of acute reduction of tem-
perature on ventricular fibrillation activation patterns. American journal of physiology Heart and circula-
tory physiology. 2002; 283(6):H2331–40. https://doi.org/10.1152/ajpheart.00207.2002 PMID:
12427594.
26. Harada M, Honjo H, Yamazaki M, Nakagawa H, Ishiguro YS, Okuno Y, et al. Moderate hypothermia
increases the chance of spiral wave collision in favor of self-termination of ventricular tachycardia/fibril-
lation. American journal of physiology Heart and circulatory physiology. 2008; 294(4):H1896–905.
https://doi.org/10.1152/ajpheart.00986.2007 PMID: 18310522.
27. Liu YB, Peter A, Lamp ST, Weiss JN, Chen PS, Lin SF. Spatiotemporal correlation between phase sin-
gularities and wavebreaks during ventricular fibrillation. Journal of cardiovascular electrophysiology.
2003; 14(10):1103–9. https://doi.org/10.1046/j.1540-8167.2003.03218.x PMID: 14521665.
28. Erkapic D, Greiss H, Pajitnev D, Zaltsberg S, Deubner N, Berkowitsch A, et al. Clinical impact of a novel
three-dimensional electrocardiographic imaging for non-invasive mapping of ventricular arrhythmias-a
prospective randomized trial. Europace: European pacing, arrhythmias, and cardiac electrophysiology:
journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of
the European Society of Cardiology. 2015; 17(4):591–7. https://doi.org/10.1093/europace/euu282
PMID: 25349226.
29. Xing D, Kjolbye AL, Nielsen MS, Petersen JS, Harlow KW, Holstein-Rathlou NH, et al. ZP123 increases
gap junctional conductance and prevents reentrant ventricular tachycardia during myocardial ischemia
in open chest dogs. Journal of cardiovascular electrophysiology. 2003; 14(5):510–20. Epub 2003/06/
05. https://doi.org/10.1046/j.1540-8167.2003.02329.x PMID: 12776869.
30. Kjolbye AL, Dikshteyn M, Eloff BC, Deschenes I, Rosenbaum DS. Maintenance of intercellular coupling
by the antiarrhythmic peptide rotigaptide suppresses arrhythmogenic discordant alternans. American
journal of physiology Heart and circulatory physiology. 2008; 294(1):H41–9. https://doi.org/10.1152/
ajpheart.01089.2006 PMID: 17982010.
Ventricular divergence and epicardial wavebreaks
PLOS ONE | https://doi.org/10.1371/journal.pone.0228818 February 21, 2020 18 / 19
31. Choi BR, Jang W, Salama G. Spatially discordant voltage alternans cause wavebreaks in ventricular
fibrillation. Heart rhythm. 2007; 4(8):1057–68. https://doi.org/10.1016/j.hrthm.2007.03.037 PMID:
17675081; PubMed Central PMCID: PMC2137164.
32. Cao JM, Qu Z, Kim YH, Wu TJ, Garfinkel A, Weiss JN, et al. Spatiotemporal heterogeneity in the induc-
tion of ventricular fibrillation by rapid pacing: importance of cardiac restitution properties. Circulation
research. 1999; 84(11):1318–31. https://doi.org/10.1161/01.res.84.11.1318 PMID: 10364570.
33. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable car-
dioverter-defibrillator for congestive heart failure. The New England journal of medicine. 2005; 352
(3):225–37. https://doi.org/10.1056/NEJMoa043399 PMID: 15659722.
Ventricular divergence and epicardial wavebreaks
PLOS ONE | https://doi.org/10.1371/journal.pone.0228818 February 21, 2020 19 / 19
